Showing results (651-660 of 1,188) with videos related to

Sort By:
Pageof 119
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2014
A phase I study of oral ARRY-614, a p38 MAPK/Tie2 dual inhibitor, in patients with low or intermediate-1 risk myelodysplastic syndromesGuillermo Garcia-Manero, Hanna J Khoury, Elias Jabbour, et al.
American Journal of Hematology|September 2, 2022
Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD Anderson experience in 174 patientsGautam Borthakur, Farhad Ravandi, Keyur Patel, et al.
American Journal of Hematology|July 21, 2018
Sorafenib Combined with 5-azacytidine in Older Patients with Untreated FLT3-ITD Mutated Acute Myeloid LeukemiaMaro Ohanian, Guillermo Garcia-Manero, Mark Levis, et al.
American Journal of Hematology|March 21, 2013
Prognostic impact of RAS mutations in patients with myelodysplastic syndromeAref Al-Kali, Alfonso Quintás-Cardama, Raja Luthra, et al.
American Journal of Hematology|June 17, 2022
Blinatumomab is associated with favorable outcomes in patients with B-cell lineage acute lymphoblastic leukemia and positive measurable residual disease at a threshold of 10-4 and higherElias J Jabbour, Nicholas J Short, Nitin Jain, et al.
American Journal of Hematology|April 4, 2017
Natural history of chronic myelomonocytic leukemia treated with hypomethylating agentsAna Alfonso, Guillermo Montalban-Bravo, Koichi Takahashi, et al.
American Journal of Hematology|April 30, 2014
Phase II trial of hyper CVAD and dasatinib in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia or blast phase chronic myeloid leukemiaOhad Benjamini, Theresa Liu Dumlao, Hagop Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 28, 2014
Prognostic implications of chromosome 17 abnormalities in the context of monosomal karyotype in patients with acute myeloid leukemia and complex cytogeneticsAziz Nazha, Hagop M Kantarjian, Vijaya R Bhatt, et al.
Blood Advances|February 28, 2025
A pharmacokinetic and safety study of oral arsenic trioxide in patients with acute promyelocytic leukemiaFarhad Ravandi, Sravanti Rangaraju, Hagop Kantarjian, et al.
Cancers|September 9, 2022
Novel UHRF1-MYC Axis in Acute Lymphoblastic LeukemiaSoyoung Park, Ali H Abdel Sater, Johannes F Fahrmann, et al.
Pageof 119